Carter's Seeks Approval for Dilutive Equity Plan Amidst Executive Compensation Scrutiny Following Poor 2025 Performance
summarizeSummary
Carter's filed its definitive proxy statement for the upcoming annual meeting, seeking shareholder approval for an amended equity incentive plan that could result in approximately 7% dilution, alongside detailing executive compensation for a year marked by significant declines in net income and EPS.
check_boxKey Events
-
Shareholder Meeting Scheduled
The 2026 Annual Meeting of Stockholders will be held virtually on Wednesday, May 13, 2026, at 1:00 p.m. Eastern Time.
-
Proposed Equity Incentive Plan Expansion
Shareholders are asked to approve an amended equity incentive plan, increasing the maximum number of shares available for issuance by 2,000,000 new shares, plus 582,345 previously authorized but unissued shares, totaling 2,582,345 shares. This represents a potential dilution of approximately 7.00% of current outstanding shares.
-
Executive Compensation Details Amidst Poor Performance
The filing details fiscal 2025 executive compensation, including a $1.2 million base salary and a $4.95 million grant date fair value for the new CEO's sign-on equity. This comes after a 50.6% decline in adjusted diluted EPS and a 69% dividend cut in fiscal 2025, with the CEO's pay ratio to the median employee reported as 542:1.
-
Board Composition Changes
Two current directors, Mr. Montgoris and Ms. Borenstein, are not standing for re-election at the upcoming annual meeting.
auto_awesomeAnalysis
This definitive proxy statement outlines key proposals for Carter's 2026 Annual Meeting, most notably a request for shareholder approval to increase the shares available under its equity incentive plan by 2,582,345 shares. This represents a potential dilution of approximately 7.00% based on current outstanding shares, which is a significant capital event. The filing also details executive compensation for fiscal 2025, a year characterized by a steep 50.6% decline in adjusted diluted EPS and a 69% cut in the quarterly dividend, as previously reported. The compensation includes a $1.2 million base salary and a $4.95 million grant date fair value for the new CEO's sign-on equity, alongside a 542:1 pay ratio, which may draw scrutiny given the company's recent financial performance. Investors should carefully consider the dilutive impact of the equity plan and the executive compensation structure in light of the company's challenging financial results and ongoing restructuring efforts.
At the time of this filing, CRI was trading at $35.59 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $23.38 to $44.44. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.